Cite
HARVARD Citation
Blin, P. et al. (2019). Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation. Clinical pharmacology & therapeutics. 105 (6), pp. 1439-1455. [Online].